How long after discontinuing sertraline (selective serotonin reuptake inhibitor) will medication-induced tremors disappear?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sertraline-Induced Tremors: Resolution Timeline After Discontinuation

Sertraline-induced tremors typically resolve within 1-2 weeks after discontinuation of the medication, though in some cases symptoms may persist for up to 4 weeks.

Understanding Sertraline-Induced Tremors

Tremor is one of the most common movement disorders associated with selective serotonin reuptake inhibitors (SSRIs) like sertraline (Zoloft) 1. These medication-induced tremors are part of the known side effect profile of SSRIs and can impact a patient's quality of life.

Mechanism and Risk Factors

Sertraline-induced tremors are believed to be related to the drug's serotonergic effects. Risk factors that may increase the likelihood or severity of tremors include:

  • Polypharmacy
  • Male gender
  • Older age
  • Higher doses of sertraline
  • Immediate-release preparations
  • Reaching toxic levels of the medication 1

Timeline for Resolution After Discontinuation

The resolution of sertraline-induced tremors follows a predictable pattern in most cases:

  • Most tremors begin to improve within the first few days after discontinuation
  • Complete resolution typically occurs within 1-2 weeks 2
  • In rare cases, symptoms may persist for up to 4 weeks 2

It's important to note that abrupt discontinuation of sertraline may lead to discontinuation syndrome, which can include its own set of symptoms including dizziness, headache, nausea, and sensory disturbances that might complicate the assessment of tremor resolution 3.

Management Approach for Discontinuation

Tapering Schedule

To minimize both discontinuation symptoms and to allow for gradual resolution of tremors:

  1. Implement a slow tapering schedule over 10-14 days rather than abrupt discontinuation 2
  2. Consider the half-life of sertraline (approximately 32 hours) when planning the taper 4
  3. Monitor for both improvement in tremor and emergence of discontinuation symptoms

Special Considerations

  • In patients with severe tremors affecting quality of life, a more rapid discontinuation might be considered with close monitoring
  • For patients with a history of discontinuation syndrome, a more gradual taper extending beyond 14 days may be warranted
  • If tremors persist beyond 4 weeks after complete discontinuation, consider evaluation for other causes of tremor

Potential Complications and Monitoring

During the discontinuation period, be alert for:

  • Emergence of discontinuation syndrome symptoms (dizziness, headache, nausea, electric shock-like sensations)
  • Orthostatic hypotension, which has been reported during sertraline withdrawal 5
  • Recurrence of the psychiatric condition for which sertraline was prescribed

Alternative Medication Considerations

If continued antidepressant treatment is needed, consider:

  • SSRIs with potentially lower risk of tremor
  • Non-SSRI antidepressants such as mirtazapine (Remeron) or bupropion (Wellbutrin) 2
  • For older patients specifically, citalopram, escitalopram, or mirtazapine may be better tolerated 2

Key Takeaways

  • Most sertraline-induced tremors resolve within 1-2 weeks after discontinuation
  • Tapering over 10-14 days is recommended to minimize discontinuation symptoms
  • Persistent tremors beyond 4 weeks after complete discontinuation warrant further evaluation
  • Alternative antidepressants with lower tremor risk should be considered if continued treatment is needed

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical implications of the pharmacology of sertraline.

International clinical psychopharmacology, 1991

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.